PepsiCo CEO: GLP-1 drugs are ‘not impacting us’ ...Middle East

PepsiCo (PEP) CEO Ramon Laguarta said GLP-1 drugs for weight loss and diabetes, such as Ozempic, Wegovy, and Mounjaro, aren’t yet having an effect on the business. In the company’s second quarter earnings call on Thursday, Laguarta attributed softer sales in the quarter to a consumer behavioral shift, saying consumers have become more value-conscious, “cautious,” […] The post PepsiCo CEO: GLP-1 drugs are ‘not impacting us’ appeared first on NY Times News Today.

Hence then, the article about pepsico ceo glp 1 drugs are not impacting us was published today ( Friday 12/07/2024 - 02:53 AM ) and is available on NY Times News ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( PepsiCo CEO: GLP-1 drugs are ‘not impacting us’ )

Also on site :

• Trump berated Netanyahu? Analysts question US-Israel feud rumours
• Iran war live: US strikes Iran’s Qeshm, says Tehran attacks Kuwait, Bahrain
• Dunkin's New Limited-Edition Tumbler Is Guaranteed to Fly Off Shelves — How to Secure Yours